The study will use data to track insurance coverage as well as prior authorization requirements for GLP-1 drugs such as Ozempic and Zepbound.
Read More Ro partners with Amgen to study barriers to obesity care, GLP-1 access
Tag: ozempic
US regulators approve Wegovy pill for weight loss
Regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.
Read More US regulators approve Wegovy pill for weight loss
Novo Nordisk to offer Ozempic at $499 per month to eligible US customers
Earlier this month, Novo Nordisk said it expects continued competition from copycat version Wegovy this year and rising pressure from main U.S. rival, Eli Lilly
Read More Novo Nordisk to offer Ozempic at $499 per month to eligible US customers
Fat, not muscle: drugmakers in race for next weight-loss breakthrough
Current weight-loss methods and popular therapies like Wegovy and Zepbound result in both fat and muscle loss, which could be especially harmful for older patients.
Read More Fat, not muscle: drugmakers in race for next weight-loss breakthrough
Ozempic copies restricted after US judge denies injunction
A U.S. judge rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk’s popular drugs Ozempic and Wegovy while a legal challenge over drug shortages unfolds.
Read More Ozempic copies restricted after US judge denies injunction
15 Additional Drugs Chosen For Medicare Negotiation
The Centers for Medicare and Medicaid Services (CMS) has picked 15 more drugs for Medicare price negotiation.
Read More 15 Additional Drugs Chosen For Medicare Negotiation